What is the treatment for tinea intertrigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Intertrigo

For tinea intertrigo (dermatophyte infection in skin folds), topical antifungal therapy with azoles (clotrimazole, miconazole) or allylamines (terbinafine) is the first-line treatment, applied once or twice daily for 2-4 weeks, with oral therapy reserved for extensive disease or treatment failure. 1, 2, 3

Initial Treatment Approach

Topical Therapy (First-Line)

  • Apply topical azoles (clotrimazole 1%, miconazole) or terbinafine 1% cream twice daily for 2-4 weeks 1, 2
  • Terbinafine cream requires shorter treatment duration (1-2 weeks) compared to azoles (4 weeks) and demonstrates superior mycological cure rates (93.5% vs 73.1% for clotrimazole) 4, 2
  • Continue treatment for at least one week after clinical clearing to prevent relapse 2
  • Keep the infected area dry—this is critical for treatment success in intertrigo 5

When to Use Oral Therapy

Oral antifungals are indicated when: 2, 3, 6

  • The infection is extensive or covers large body surface area
  • Topical treatment has failed after 2-4 weeks
  • The patient is immunocompromised
  • Application of topical agents is not feasible

Oral Therapy Options (Second-Line)

If oral therapy is required: 7, 3

  • Itraconazole 100 mg daily for 15 days (87% mycological cure rate) 7
  • Terbinafine 250 mg daily for 1-2 weeks (particularly effective against Trichophyton tonsurans) 7, 3

Critical Adjunctive Measures

Eliminate Predisposing Factors

  • Address skin moisture and maceration in skin folds 5, 1
  • Manage obesity and diabetes if present 5
  • Use absorbent powders or barrier creams to keep areas dry 5

Prevent Reinfection

  • Clean contaminated fomites (towels, clothing) with disinfectant or 2% sodium hypochlorite solution 8, 7
  • Avoid sharing personal items 7
  • Screen and treat household contacts if anthropophilic species (T. tonsurans) is identified 8, 7

Diagnostic Confirmation

  • Obtain potassium hydroxide (KOH) preparation or culture before treatment when diagnosis is uncertain 2, 6
  • This distinguishes tinea from candidal intertrigo, which requires different treatment 5
  • For candidal intertrigo, topical azoles and polyenes (nystatin) are effective, but the clinical approach differs 5

Treatment Monitoring

  • Assess both clinical response and mycological cure—clinical clearing alone is insufficient 8, 7
  • If clinical improvement occurs but infection persists, extend treatment for 2-4 additional weeks 9, 8
  • If no improvement after 2-4 weeks of topical therapy, switch to oral antifungals 7, 3

Common Pitfalls to Avoid

  • Do not confuse tinea intertrigo with candidal intertrigo—both occur in skin folds but require different treatments 5, 1
  • Avoid stopping treatment when symptoms resolve; continue for at least one week after clinical clearing 2
  • Do not use topical corticosteroids alone, as they can worsen fungal infections; combination antifungal/steroid products should be used cautiously and only when significant inflammation is present 2
  • Search for other sites of tinea infection and treat simultaneously to prevent reinfection 1

References

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and management of tinea infections.

American family physician, 2014

Guideline

Treatment of Tinea Corporis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First-Line Treatment for Tinea Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Tinea Capitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.